Polymorphisms associated with optimization of biological therapy through drug dose reduction in moderate-to-severe psoriasis

J Eur Acad Dermatol Venereol. 2020 Jun;34(6):e271-e275. doi: 10.1111/jdv.16256. Epub 2020 Feb 21.
No abstract available

Publication types

  • Letter

MeSH terms

  • Biological Therapy
  • Drug Tapering
  • Humans
  • Pharmaceutical Preparations*
  • Psoriasis* / drug therapy
  • Psoriasis* / genetics
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Pharmaceutical Preparations